共 15 条
[1]
Hicheri Y(2012)Antifungal prophylaxis in haematology patients: the role of voriconazole Clin Microbiol Infect 18 1-15
[2]
Cook G(2011)Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation Br J Haematol 155 318-327
[3]
Cordonnier C(2004)Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants Blood 103 1527-1533
[4]
Marks DI(2012)Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies Med Mycol 50 266-269
[5]
Pagliuca A(2013)Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies Antimicrob Agents Chemother 57 3262-3267
[6]
Kibbler CC(undefined)undefined undefined undefined undefined-undefined
[7]
Marr KA(undefined)undefined undefined undefined undefined-undefined
[8]
Crippa F(undefined)undefined undefined undefined undefined-undefined
[9]
Leisenring W(undefined)undefined undefined undefined undefined-undefined
[10]
Hoenigl M(undefined)undefined undefined undefined undefined-undefined